A new British Journal of Clinical Pharmacology study indicates that certain markers can help predict which patients may experience problems after receiving an organ transplant.
A new British Journal of Clinical Pharmacology study indicates that certain markers can help predict which patients may experience problems after receiving an organ transplant.
The urinary markers, called miR-155-5p and CXCL10, can be measured after transplantation to predict the likelihood of acute rejection and organ dysfunction.
“Large prospective randomised multicentre trials are warranted to refine our cut-off values and validate the clinical usefulness of these biomarkers,” wrote the authors of the study.
Additional Information
Link to Study: http://onlinelibrary.wiley.com/doi/10.1111/bcp.13399/full
About Journal
The British Journal of Clinical Pharmacology (BJCP) contains papers and reports on all aspects of drug action in humans: invited review articles, original papers and correspondence. The journal enjoys a wide readership, bridging the gap between the medical profession, clinical research and the pharmaceutical industry.
Penny Smith
Tel: +44 (0)1243 770448
sciencenewsroom@wiley.com